TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 46 filers reported holding TALIS BIOMEDICAL CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,073,176 | -2.0% | 2,235,783 | 0.0% | 0.05% | -16.7% |
Q1 2023 | $1,095,534 | +9.9% | 2,235,783 | 0.0% | 0.06% | -13.0% |
Q4 2022 | $996,488 | -34.6% | 2,235,783 | 0.0% | 0.07% | -36.1% |
Q3 2022 | $1,524,000 | -16.1% | 2,235,783 | 0.0% | 0.11% | -23.4% |
Q2 2022 | $1,816,000 | -42.4% | 2,235,783 | 0.0% | 0.14% | -29.5% |
Q1 2022 | $3,152,000 | -49.9% | 2,235,783 | +42.5% | 0.20% | -44.4% |
Q4 2021 | $6,293,000 | – | 1,569,300 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|